Status:
UNKNOWN
Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo
Lead Sponsor:
Assiut University
Conditions:
Vitiligo
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Vitiligo is considered the most common chronic depigmentation disorder that affects around 0.5 -2% of the world population . In Africa , its prevelance is around 0.4% and 1.22 % in Assiut . Treatment...
Detailed Description
Vitiligo is considered the most common chronic depigmentation disorder that affects around 0.5 -2% of the world population .In Africa , its prevelance is around 0.4% and 1.22 % in Assiut . Vitiligo m...
Eligibility Criteria
Inclusion
- Age from 20-60 years old
- Avoid using any other treatment modalities for vitiligo during the course of the study
Exclusion
- Pregnant and lactating women
- local medications or laser therapy one month prior to the study
- bleeding disorders
- history of keloid formation
- photosensitivity
- seizure disorders
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 24 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04320160
Start Date
August 1 2020
End Date
October 24 2022
Last Update
March 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.